rs863224446
Variant summary
Our verdict is Pathogenic. Variant got 14 ACMG points: 14P and 0B. PM2PP3_StrongPP5_Very_Strong
The NM_001042492.3(NF1):c.2850G>A(p.Gln950Gln) variant causes a splice region, synonymous change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Pathogenic (★★).
Frequency
Consequence
NM_001042492.3 splice_region, synonymous
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 14 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NF1 | NM_001042492.3 | c.2850G>A | p.Gln950Gln | splice_region_variant, synonymous_variant | Exon 21 of 58 | ENST00000358273.9 | NP_001035957.1 | |
NF1 | NM_000267.3 | c.2850G>A | p.Gln950Gln | splice_region_variant, synonymous_variant | Exon 21 of 57 | NP_000258.1 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Neurofibromatosis, type 1 Pathogenic:2
This sequence change affects codon 950 of the NF1 mRNA. It is a 'silent' change, meaning that it does not change the encoded amino acid sequence of the NF1 protein. RNA analysis indicates that this variant induces altered splicing and may result in an absent or altered protein product. This variant is not present in population databases (gnomAD no frequency). This variant has been observed in individual(s) with clinical features of neurofibromatosis type I (PMID: 21520333, 26740943, 31717729). In at least one individual the variant was observed to be de novo. ClinVar contains an entry for this variant (Variation ID: 561684). Variants that disrupt the consensus splice site are a relatively common cause of aberrant splicing (PMID: 17576681, 9536098). Studies have shown that this variant results in r.2618_2850del, and produces a non-functional protein and/or introduces a premature termination codon (PMID: 26740943; Invitae). For these reasons, this variant has been classified as Pathogenic. -
- -
not provided Pathogenic:1
Exonic splice site variant demonstrated to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease (PMID: 26740943); Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 31717729, 31766501, 26740943) -
Hereditary cancer-predisposing syndrome;CN230736:Cardiovascular phenotype Pathogenic:1
The c.2850G>A pathogenic mutation (also known as p.Q950Q), located in coding exon 21 of the NF1 gene, results from a G to A substitution at nucleotide position 2850. This nucleotide substitution does not change the glutamine at codon 950. However, this change occurs in the last base pair of coding exon 21, which makes it likely to have some effect on normal mRNA splicing. This mutation has been detected in multiple individuals with a clinical or suspected diagnosis of neurofibromatosis type 1 (NF1); it occurred de novo in one of the individuals (Bianchessi D et al. Mol Genet Genomic Med, 2015 Nov;3:513-25; Melloni G et al. Cancers (Basel), 2019 11;11:; Yao R et al. Genes (Basel), 2019 10;10:; Ambry internal data). In addition, this alteration results in the deletion of 233 nucleotides, leading to a frameshift in the NF1 protein (Bianchessi D et al. Mol Genet Genomic Med, 2015 Nov;3:513-25; Ambry internal data). Based on the supporting evidence, this alteration is interpreted as a disease-causing mutation. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at